Showing results (121-130 of 352) with videos related to

Sort By:
Pageof 36
Expert Review of Anticancer Therapy|September 21, 2011
Determination of cut-offs for circulating tumor cell measurement in metastatic cancerJimmy Jacob, Jonathan Krell, Leandro Castellano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2012
Whole blood stem cell reinfusion and escalated dose melphalan in castration-resistant prostate cancer: a phase 1 studyJonathan Shamash, Jimmy Jacob, Samir Agrawal, et al.
Frontiers in Oncology|April 25, 2022
Targeting ALK Rearrangements in NSCLC: Current State of the ArtLing Peng, Liping Zhu, Yilan Sun, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 9, 2009
The nucleoside backbone affects durability of efavirenz- or nevirapine-based highly active antiretroviral therapy in antiretroviral-naive individualsNaa Torshie Annan, Mark Nelson, Sundhiya Mandalia, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2004
Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control studyRachael Jones, Justin Stebbing, Mark Nelson, et al.
The Journal of Antimicrobial Chemotherapy|February 6, 2004
A randomized trial to investigate the recycling of stavudine and didanosine with and without hydroxyurea in salvage therapy (RESTART)Justin Stebbing, Mark Nelson, Chloe Orkin, et al.
Expert Review of Molecular Diagnostics|October 30, 2016
Investigating miRNA-mRNA regulatory networks using crosslinking immunoprecipitation methods for biomarker and target discovery in cancerMireia Mato Prado, Adam E Frampton, Elisa Giovannetti, et al.
American Journal of Hematology|February 9, 2008
HIV-associated multicentric Castleman's diseaseJustin Stebbing, Liron Pantanowitz, Farshid Dayyani, et al.
Pageof 36